India Moves To Block Loophole Allowing Pharmas To Exceed Price Caps
This article was originally published in PharmAsia News
Executive Summary
India's regulator of drug prices now requires Indian drug makers to seek a separate price if they change the composition of existing drugs. The move by the National Pharmaceutical Pricing Authority is intended to block the practice of evading price controls by changing an approved composition of a drug already under price controls. The move is seen as preventing many drug makers manufacturing in India from changing the composition by adding something such as a fatty acid or wheat germ oil to a drug to justify an unregulated price. (Click here for more